Society Pass (SOPA) Research Reports
RESEARCH REPORT ARCHIVE
December 27th, 2023. Litchfield Hills Research - $4.00 Price Target.
Adding Society Pass (SOPA) $0.96 to the Watch List
Amazing Fast Grower, in the Asian Silicon Valley.
After a wildly successful IPO debut and subsequent tumble, Society...
PNF Accountants & Advisors Cocktail Hour!
Thursday, 6:00 PM at Hagerty Garage & Social
Tonya Notaro
Hagerty...
Ouch, for Now. Progressive Care Does 200:1 Reverse.
MASSIVE REVERSE SPLIT
Let's just watch from the sidelines for...
Silo Pharma (SILO) Trades up 90% Friday, With 23 Million Shares Traded!
And We Weren't Watching!
It was Friday after all, and the last day of the year, and we were...
Silo Pharma (SILO) Announces Positive Study Results of SPU- 21 for Arthritis
SPU-21 effective in controlling arthritis progression.
SPU-21 Demonstrates Positive Data in Arthritis Suppression using Silo’s Novel Joint Homing Peptide
Carbon Credit Charts.
Carbon Streaming Corp. (OFSTF)
Base Carbon...
Ardelyx (ARDX). Don’t be Nervous, It’s Just Money.
The Higher it Goes, The More Nervous we Get.
LIVE QUOTE
Smart for Life (SMFL) Announces Launch of Greens First Protein Bars.
New Line of Protein Bars Specifically Formulated with the Greens First PRO Line, Provides a Nutrient Dense Meal Replacement with 54 Super...
FDA to Ardelyx: “Give us a Couple More Weeks.” (ARDX) $1.80.
Oh boy, another day, another snag. There goes our Christmas bonus, dang.
LIVE QUOTE
It's been...
Latest article
Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!
When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...
GeoVax to Provide Corporate Update on Tuesday May 14, 2024.
Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...
NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...
Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...
